Geriatric 6 PDF
Geriatric 6 PDF
Geriatric 6 PDF
RESEARCH ARTICLE
Open Access
Abstract
Background: Frailty can be defined as a progressive loss of reserve and adaptive capacity associated with an overall
deterioration in health that can result in disability, loss of independence, hospitalisation, extensive use of healthcare
resources, admission to long-term care and death. Nevertheless, despite widespread use of the term, there is no
agreement on the definition of frailty or an instrument to identify it in a straightforward way. The purpose of the
current study was to explore which factors are associated with frailty-related adverse outcomes in elderly individuals
and to propose a suitable tool for identifying such individuals, particularly in primary care settings.
Methods: A prospective open cohort study of community dwelling, independent individuals aged 75 or over, followed
up for 2 years. The study was entirely conducted in a primary care setting. Study variables included independence status
measured by Barthels Index and the Lawton Instrumental Activities of Daily Living Scale, functional performance, assessed
by Timed Up and Go (TUG) and Gait Speed (GS) tests and levels of polipharmacy, comorbidity and social support.
Outcome variables were specific frailty-related adverse events, namely, loss of independence and death.
Results: Overall, 215 community-dwelling independent individuals initiated the study. Of these, 46 were lost to
follow-up and 50 had frailty-related adverse events during the follow-up period. Individuals with adverse
events during the study had poorer functional status at baseline. The multivariate model that best explained
the occurrence of these events included the variables of age, presence of polipharmacy and the TUG time.
The AUC (Area under the curve) of this model was 0.822.
Conclusions: Given the simplicity of assessing the three derived factors and their combined discriminant
power, the proposed model may be considered a suitable tool for identifying frail patients, i.e., people more
likely to lose their independence or die within a relatively short time interval.
Keywords: Frailty, Identification, Primary care
Background
Frailty can be defined as a progressive loss of reserve and
adaptive capacity associated with an overall deterioration
in health that can result in disability, loss of independence,
hospitalisation, extensive use of healthcare resources, admission to long-term care and death [13]. Nevertheless,
despite the widespread use of the term, there is no agreement on the definition of frailty [4, 5] or on an instrument
to identify it [6] in a straightforward way, particularly in
primary care.
* Correspondence: [email protected]
2
Unidad de Investigacin AP-OSIs de Gipuzkoa, Osakidetza, Instituto
Investigacin Sanitaria Biodonostia, REDISSEC, Paseo Dr. Begiristain s/n, San
Sebastian-Donostia 20014, Spain
Full list of author information is available at the end of the article
Three approaches for the identification of frail individuals have been described in the literature [7]: the
rules-based, the cumulative and the clinical judgment.
Rules-based approaches are derived from multiple
regression models and are based on the presence of a
number of symptoms. The phenotypic approach would
be included in this group [1]. Cumulative-based
approaches are based on the consideration and addition
of the number of impairments presented by a single
person [8]. Finally, clinical judgment based approaches
rely on the professional interpretation of the clinical
record and physical examinations [7].
A frequently considered aspect in the aforementioned
approaches is functional performance. Several instruments
2016 Diez-Ruiz et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Methods
Study population and recruitment
Page 2 of 8
Page 3 of 8
Results
A total of n = 215 individuals were initially included in
the study and of those n = 169 completed the proposed
follow-up. No significant differences were found in
terms of socio-demographic and clinical characteristics
between lost to follow-up subjects and those who completed the study. At the end of the follow-up period, n
= 119 subjects remained independent, while the other
n = 50 participants (24 %) had a frailty-related adverse
outcome: death (n = 8) or loss of independence (n = 42)
(Fig. 1). The rates of independence loss in the first and
second years were 8.3 and 2.6 %, respectively.
At baseline, participants had a mean age of 79.4
(SD: 4.1) years and 63 % were women. A high proportion of subjects presented comorbidity (72 %) and
polipharmacy (61 %). Comparing the baseline status
of those who eventually developed a frailty-related
adverse outcome and those who did not, we observed
the following. The adverse outcome group was on
average 3 years older (p < 0.001), had a lower level of
physical activity (p = 0.001) and was more likely to
present polipharmacy (p = 0.001) or comorbidity (p =
0.032). In addition, it presented more hospital admissions in the previous year (p = 0.013) and declared a
poorer self-perceived health status. No significant differences were found in the variables of sex, body
mass index, visual or auditory deficits and accidental
falls in the previous year (Table 1).
As far as functional status is concerned, participants
who developed frailty-related adverse outcomes, despite
being independent at baseline, had lower levels of functioning in terms of basic activities of daily living
(Barthels index) and IADL (Lawtons score). Significant
differences were also observed in the functional
Page 4 of 8
Page 5 of 8
Table 1 Baseline data of the entire sample and comparison between the two groups of adverse events
Adverse event
Baseline variables
Total (N = 215)
Yes (n = 50)
No (n = 119)
p-value
79.4 (4.1)
81.7 (4.6)
78.4 (3.5)
<0.001
Sex: Female
136 (63)
32 (64)
76 (64)
0.987
205 (95)
47 (94)
114 (96)
0.695
162 (75)
35 (70)
88 (74)
0.599
18 (8)
6 (12)
5 (4)
0.085
22 (10)
11 (22)
6 (5)
0.001
Polipharmacy
131 (61)
41 (82)
65 (55)
0.001
52 (24)
12 (24)
30 (25)
0.868
36 (17)
13 (26)
13 (11)
0.013
136 (63)
26 (52)
91 (77)
0.003
Self-perceived health
Good/very good
Fair
73 (34)
23 (46)
26 (22)
Poor/very poor
7 (3)
1 (2)
2 (1)
10 (9, 12)
10 (8, 12)
10 (9, 12)
0.442
Comorbidity: Yes
153 (72)
35 (70)
62 (52)
0.032
63 (29)
18 (36)
33 (28)
0.285
52 (24)
17 (34)
21 (18)
0.020
37 (17)
8 (16)
23 (19)
0.610
12 (6)
6 (12)
1 (1)
0.003
8 (4)
3 (6)
2 (1)
0.154
6 (3)
1 (2)
4 (4)
1.000
Visual deficit
Auditory deficit b
Adverse event: death or loss of independence defined as 10 % drop in Barthels score compared to baseline, during the follow-up. Data are expressed as frequencies
(percentages), unless otherwise stated. For dichotomous variables one of the two categories are presented.
a
Presented health problems are not exclusive; a patient can suffer by more than one. P values in the last column refer to comparisons between the groups with
and without adverse events (Yes vs. No). Age was compared with Students t test
b
these variables were compared with Fishers exact test, the Chi-square test was implemented for the rest of the variables
Discussion
Proper identification of frail individuals in primary care
represents an unresolved challenge. The current study,
Table 2 Baseline data on functioning and comparison between groups with and without adverse frailty-related outcomes
Adverse event
Functional tests
Yes (n = 50)
No (n = 119)
p-value
90 points
16 (32)
7 (6)
<0.001
95100 points
34 (68)
112 (94)
6 (4, 8)
8 (5, 8)
<0.001
15 (13, 22)
<0.001
0.8 (0.2)
1.1 (0.2)
<0.001
Categorical variables were compared with the chi-squared test; means and medians were compared using the Students t and Wilcoxon tests, respectively
Adverse event death or loss of independence defined as 10 % drop in Barthels score compared to baseline, during the follow-up, IADL Instrumental activities of
daily living. The abbreviations: s and m/s indicate seconds and meters per second respectively. Q1, Q3 interquartile range from the first to the third quartile, SD
standard deviation
Page 6 of 8
Odds ratio
95 % CI
p-value
Age, years
1.14
1.03, 1.25
0.012
1.28
1.14, 1.44
<0.001
No
Ref
Yes
2.74
1.06, 7.06
0.037
Polipharmacy
Goodness-of-fit statistics
Area under the curve: 0.822
R squared / adjusted R squared: 0.270/ 0.384
Hosmer-Lemeshow: p = 0.721
The probability of suffering a frailty-related adverse event during the follow-up
period was modelled. Adverse event: death or loss of independence defined
as 10 % drop in Barthels score compared to baseline, during the follow-up,
95 % CI: 95 % confidence interval. Polypharmacy: long-term prescription of 4
drugs. The model is based on n = 50 adverse events and n = 118 positive
events due to 1 missing value in TUG test
Fig. 2 ROC of the proposed model for identifying frailty in primary care.
Receiver operating characteristic curve for the final model to
predict frailty-related outcomes, based on age, Timed Up and Go
time and polypharmacy status. The curve represents the relationship
between sensitivity and 1-specificity for all potential cut-off points of
the diagnostic test under study. The area under the curve (AUC), a
measure of the discriminatory power of the test, is 0.822. The cut-off
point that maximises sensitivity and specificity (i.e., 76 %) is 0.288
Conclusions
It is possible to identify frail individuals considering their
age, polipharmacy status and functional capacity. These
Page 7 of 8
Not applicable.
Availability of data and materials
The database set was available for all authors of the study
and will be available for other non-commercial researches
on request.
Abbreviations
AUC: area under the curve; BADL: basic activities of daily living;
CI: confidence intervals; GS: gait speed; IADL: Instrumental activities of daily
living; OR: odds; PRISMA: Program of research to integrate services for the
maintenance of autonomy; SD: standard deviations; SHARE: Survey of health,
ageing and retirement in Europe; TUG: Timed up and go.
Competing interests
The authors declare that they have no competing interests.
Authors contributions
AD, AB, JN, KV, IS, IV have made substantial contributions to conception and
design of the study; KV, performed the analysis and IV, AB, AD, IS interpreted
the data; IV, KV have been involved in drafting the manuscript and AD
revised it critically for important intellectual content; AD, AB, JN, KV, IS, IV
have given final approval of the version to be published and agree to be
accountable for all aspects of the work in ensuring that questions related to
the accuracy or integrity of any part of the work are appropriately
investigated and resolved.
Acknowledgements
Authors wish to thank all the participants who took part on this study for
their interest and generous dedication.
Funding
Gobierno Vasco- Eusko Jaurlaritza. Departamento de Sanidad y Consumo.
Ayudas investigacin sanitarias 2011. Proyecto N: 2011111122.
Author details
1
Centro de Salud Errenteria-Beraun, OSI Donostialdea, Osakidetza, Errentera,
Gipuzkoa, Spain. 2Unidad de Investigacin AP-OSIs de Gipuzkoa, Osakidetza,
Instituto Investigacin Sanitaria Biodonostia, REDISSEC, Paseo Dr. Begiristain
s/n, San Sebastian-Donostia 20014, Spain.
Received: 4 January 2016 Accepted: 21 April 2016
References
1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al.
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med
Sci. 2001;56 (3).
2. Lacas A, Rockwood K. Frailty in primary care: a review of its conceptualization
and implications for practice. BMC Med. 2012;10:4.
3. Garcia-Garcia FJ, Alfaro AA. Fragilidad: de la epidemiologa a la clnica. Rev
Esp Geriatr Gerontol. 2010;45:2501.
4. Santos-Eggimann B, Karmaniola A, Seematter-Bagnoud L, Spagnoli J, Bula C,
Cornuz J, et al. The Lausanne cohort Lc65+: a population-based prospective
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
Page 8 of 8
30. Martin LI, Lopez-Torres Hidalgo JD, Gorronogoitia IA, De-Hoyos Alonso MC,
Baena Diez JM, Herreros HY. [Preventive activities in the elderly]. Aten
Primaria. 2014;46 Suppl 4:7581.
31. Badia X. Estudios sobre la calidad de vida de personas afectas de diferentes
patologas. Edited by Ministerio de Sanidad y poltica social. 2009. Madrid.
Ref Type: Report.
32. Steyerberg EW. Clinical prediction models. Springer; 2009. ISBN 978-0-38777243-1 DOI 10.1007/978-0-387-77244-8.
33. Herman T, Giladi N, Hausdorff JM. Properties of the timed up and go test:
more than meets the eye. Gerontology. 2011;57:20310.
34. Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of frailty in
middle-aged and older community-dwelling Europeans living in 10
countries. J Gerontol A Biol Sci Med Sci. 2009;64:67581.
35. Sousa AC, Dias RC, Maciel AC, Guerra RO. Frailty syndrome and associated
factors in community-dwelling elderly in Northeast Brazil. Arch Gerontol
Geriatr. 2012;54:e95e101.
36. Boyd CM, Xue QL, Simpson CF, Guralnik JM, Fried LP. Frailty, hospitalization,
and progression of disability in a cohort of disabled older women. Am J
Med. 2005;118:122531.
37. Rockwood K, Hogan DB, MacKnight C. Conceptualisation and
measurement of frailty in elderly people. Drugs Aging. 2000;17:295302.
38. Romero-Ortuno R. The frailty instrument for primary care of the survey of
health, ageing and retirement in Europe predicts mortality similarly to a
frailty index based on comprehensive geriatric assessment. Geriatr Gerontol
Int. 2013;13:497504.
39. Romero-Ortuno R, OShea D, Kenny RA. The SHARE frailty instrument for
primary care predicts incident disability in a European population-based
sample. Qual Prim Care. 2011;19:3019.
40. Applegate WB, Miller ST, Graney MJ, Elam JT, Burns R, Akins DE. A
randomized, controlled trial of a geriatric assessment unit in a community
rehabilitation hospital. N Engl J Med. 1990;322:15728.
41. Vellas B, Balardy L, Gillette-Guyonnet S, Van Abellan KG, Ghisolfi-Marque A,
Subra J, et al. Looking for frailty in community-dwelling older persons: the
gerontopole frailty screening tool (GFST). J Nutr Health Aging. 2013;17:
62931.
42. van Kempen JA, Schers HJ, Melis RJ, Olde Rikkert MG. Construct validity and
reliability of a two-step tool for the identification of frail older people in
primary care. J Clin Epidemiol. 2014;67:17683.
43. van Kempen JA, Schers HJ, Philp I, Olde Rikkert MG, Melis RJ. Predictive validity
of a two-step tool to map frailty in primary care. BMC Med. 2015;13:287.
44. Fewtrell MS, Kennedy K, Singhal A, Martin RM, Ness A, Hadders-Algra M, et al.
How much loss to follow-up is acceptable in long-term randomised trials and
prospective studies? Arch Dis Child. 2008;93:45861.
45. The Epidemiology of Aging. Springer; 2012. ISBN 978-94-007-5060-9 DOI 10.
1007/978-94-007-5061-6.